random thoughts and factsThe purchase of Transforming Systems seems to have been cheaply - revenues of f £2,218,192 including recurring revenue of £1,880,962 and cash on hand ,after a closing net equity adjustment will approximately be £1,000,000 with no debt..
Transforming Systems was purchased for 6 million pounds ,when you remove the cash , you get a price of roughly 2.25 years of revenue. Part of that cheapness is due to roughly half the price being paid in shares ; as a seller you might accept a somewhat lower price to get shares that can appreciate in value.
The previous purchase of In touch was done with cash.
Oculys Health Informatics Inc. purchase was a combo - cash and shares purchase.
The recent private placement of $2.2 million was 100% insiders for M and A purposes.
The advisory is first class - general counsel of Sangoma , 2 Shen brothers from Aastra technologies andex Aastra , now Descartes CFO..
Awhile back on this board , somebody expressed the concern the Shen brothers would sell - I would think the very recent private placement might remove that concern?